References
- AbdAleati, N. S., Mohd Zaharim, N., & Mydin, Y. O. (2016). Religiousness and mental health: Systematic review study. Journal of Religion and Health, 55(6), 1929–1937. https://doi.org/https://doi.org/10.1007/s10943-014-9896-1
- Andersen, K. A. A., Carhart-Harris, R., Nutt, D. J., & Erritzoe, D. (2021). Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatrica Scandinavica, 143(2), 101–118. https://doi.org/https://doi.org/10.1111/acps.13249
- Anderson, B. T., Labate, B. C., Meyer, M., Tupper, K. W., Barbosa, P. C. R., Grob, C. S., Dawson, A., & McKenna, D. (2012). Statement on ayahuasca. The International Journal on Drug Policy, 23(3), 173–175. https://doi.org/https://doi.org/10.1016/j.drugpo.2012.02.007
- Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W. (2019). Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada. Drug and Alcohol Review, 38(7), 781–789. https://doi.org/https://doi.org/10.1111/dar.12985
- Barbosa, P. C. R., Cazorla, I. M., Giglio, J. S., & Strassman, R. (2009). A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects. Journal of Psychoactive Drugs, 41(3), 205–212. https://doi.org/https://doi.org/10.1080/02791072.2009.10400530
- Barbosa, P. C. R., Strassman, R. J., da Silveira, D. X., Areco, K., Hoy, R., Pommy, J., Thoma, R., & Bogenschutz, M. (2016). Psychological and neuropsychological assessment of regular hoasca users. Comprehensive Psychiatry, 71, 95–105. https://doi.org/https://doi.org/10.1016/j.comppsych.2016.09.003
- Barbosa, P. C. R., Tófoli, L. F., Bogenschutz, M. P., Hoy, R., Berro, L. F., Marinho, E. A. V., Areco, K. N., & Winkelman, M. J. (2018). Assessment of alcohol and tobacco use disorders among religious users of ayahuasca. Frontiers in Psychiatry, 9, 136. https://doi.org/https://doi.org/10.3389/fpsyt.2018.00136
- Bastos, F. I. P. M., Vasconcellos, M. T. L. d., De Boni, R. B., Reis, N. B. d., & Coutinho, C. F. d S. (2017). III Levantamento Nacional sobre o uso de drogas pela população brasileira [III National Survey on drug use by the Brazilian population]. ICICT/FIOCRUZ. Retrieved from https://www.arca.fiocruz.br/handle/icict/34614
- Berlowitz, I., Walt, H., Ghasarian, C., Mendive, F., & Martin-Soelch, C. (2019). Short-term treatment effects of a substance use disorder therapy involving traditional amazonian medicine. Journal of Psychoactive Drugs, 51(4), 323–334. https://doi.org/https://doi.org/10.1080/02791072.2019.1607956
- Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77. https://doi.org/https://doi.org/10.1016/S0022-3999(01)00296-3
- Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299. https://doi.org/https://doi.org/10.1177/0269881114565144
- Botega, N. J., Bio, M. R., Zomignani, M. A., Garcia, C., Jr., & Pereira, W. A. B. (1995). Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Revista de Saúde Pública, 29(5), 359–363. https://doi.org/https://doi.org/10.1590/S0034-89101995000500004
- Bouso, J. C., dos Santos, R. G., Alcázar-Córcoles, M. Á., & Hallak, J. E. C. (2018). Serotonergic psychedelics and personality: A systematic review of contemporary research. Neuroscience and Biobehavioral Reviews, 87, 118–132. https://doi.org/https://doi.org/10.1016/j.neubiorev.2018.02.004
- Bouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., & Riba, J. (2015). Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. European Neuropsychopharmacology, 25(4), 483–492. https://doi.org/https://doi.org/10.1016/j.euroneuro.2015.01.008
- Brissac, S. (2010). In the light of Hoasca: An approach to the religious experience of participants of the União do Vegetal. In B. C. Labate & E. MacRae (Eds.), Ayahuasca, ritual and religion in Brazil (pp. 135–160). Equinox.
- Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2020). Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: Clinical and forensic impact. Pharmaceuticals, 13(11), 334. https://doi.org/https://doi.org/10.3390/ph13110334
- Callaway, J. C., Airaksinen, M. M., McKenna, D. J., Brito, G. S., & Grob, C. S. (1994). Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology, 116(3), 385–387. https://doi.org/https://doi.org/10.1007/bf02245347
- Cameron, L. P., & Olson, D. E. (2018). Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT). ACS Chemical Neuroscience, 9(10), 2344–2357. https://doi.org/https://doi.org/10.1021/acschemneuro.8b00101
- Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015). LSD enhances suggestibility in healthy volunteers. Psychopharmacology, 232(4), 785–794. https://doi.org/https://doi.org/10.1007/s00213-014-3714-z
- Cata-Preta, E. G., Serra, Y. A., Moreira-Junior, E. d C., Reis, H. S., Kisaki, N. D., Libarino-Santos, M., Silva, R. R. R., Barros-Santos, T., Santos, L. C., Barbosa, P. C. R., Costa, J. L., Oliveira-Lima, A. J., Berro, L. F., & Marinho, E. A. V. (2018). Ayahuasca and its DMT - and β-carbolines – containing ingredients block the expression of ethanol-induced conditioned place preference in mice: Role of the treatment environment. Frontiers in Pharmacology, 9, 561. https://doi.org/https://doi.org/10.3389/fphar.2018.00561
- Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Pic-Taylor, A., Mortari, M. R., & Caldas, E. D. (2020). Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats. Metabolic Brain Disease, 35(5), 739–751. https://doi.org/https://doi.org/10.1007/s11011-020-00547-w
- Cruz, J. I., & Nappo, S. A. (2018). Is ayahuasca an option for the treatment of crack cocaine dependence? Journal of Psychoactive Drugs, 50(3), 247–255. https://doi.org/https://doi.org/10.1080/02791072.2018.1447174
- Daldegan-Bueno, D., Favaro, V. M., Morais, P., Sussulini, A., & Oliveira, M. (2022). Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field. Behavioural brain research, 113878. Advance online publication. https://doi.org/https://doi.org/10.1016/j.bbr.2022.113878
- Daldegan-Bueno, D., Maia, L. O., Massarentti, C. M., & Tófoli, L. F. (2022). Ayahuasca and tobacco smoking cessation: Results from an online survey in Brazil. Psychopharmacology. Advance online publication. https://doi.org/https://doi.org/10.1007/s00213-022-06063-2
- Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2020.3285
- de Almeida, R. N., Galvão, A. C. d M., da Silva, F. S., Silva, E. A. D. S., Palhano-Fontes, F., Maia-de-Oliveira, J. P., de Araújo, L.-S B., Lobão-Soares, B., & Galvão-Coelho, N. L. (2019). Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: Observation from a randomized controlled trial. Frontiers in Psychology, 10, 1234. https://doi.org/https://doi.org/10.3389/fpsyg.2019.01234
- de Rios, M. D., Grob, C. S., & Baker, J. R. (2002). Hallucinogens and Redemption. Journal of Psychoactive Drugs, 34(3), 239–248. https://doi.org/https://doi.org/10.1080/02791072.2002.10399960
- Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The Satisfaction With Life Scale. Journal of Personality Assessment, 49(1), 71–75. https://doi.org/https://doi.org/10.1207/s15327752jpa4901_13
- Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016). Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Research Bulletin, 126(Pt 1), 89–101. https://doi.org/https://doi.org/10.1016/j.brainresbull.2016.03.002
- dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. (2016a). The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. Journal of Psychopharmacology, 30(12), 1230–1247. https://doi.org/https://doi.org/10.1177/0269881116652578
- dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. C. (2016b). Antidepressive and anxiolytic effects of ayahuasca: A systematic literature review of animal and human studies. Revista Brasileira de Psiquiatria, 38(1), 65–72. https://doi.org/https://doi.org/10.1590/1516-4446-2015-1701
- Favaro, V. M., Yonamine, M., Soares, J. C. K., & Oliveira, M. G. M. (2015). Effects of long-term ayahuasca administration on memory and anxiety in rats. PLoS One, 10(12), e0145840. https://doi.org/https://doi.org/10.1371/journal.pone.0145840
- Fleck, M. P., Louzada, S., Xavier, M., Chachamovich, E., Vieira, G., Santos, L., & Pinzon, V. (2000). Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida "WHOQOL-bref. Revista de Saúde Pública, 34(2), 178–183.https://doi.org/https://doi.org/10.1590/S0034-89102000000200012
- Galvão, A. C. d M., de Almeida, R. N., Silva, E. A. D. S., Freire, F. A. M., Palhano-Fontes, F., Onias, H., Arcoverde, E., Maia-de-Oliveira, J. P., de Araújo, D. B., Lobão-Soares, B., & Galvão-Coelho, N. L. (2018). Cortisol modulation by ayahuasca in patients with treatment resistant depression and healthy controls. Frontiers in Psychiatry, 9, 185. https://doi.org/https://doi.org/10.3389/fpsyt.2018.00185
- Galvão-Coelho, N. L., Marx, W., Gonzalez, M., Sinclair, J., de Manincor, M., Perkins, D., & Sarris, J. (2021). Classic serotonergic psychedelics for mood and depressive symptoms: A meta-analysis of mood disorder patients and healthy participants. Psychopharmacology, 238(2), 341–354. https://doi.org/https://doi.org/10.1007/s00213-020-05719-1
- Gianfratti, B., Tabach, R., Sakalem, M. E., Stessuk, T., Maia, L. O., & Carlini, E. A. (2022). Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity. Journal of Ethnopharmacology, 285, 114865. https://doi.org/https://doi.org/10.1016/j.jep.2021.114865
- Gonzalez, D., Cantillo, J., Perez, I., Carvalho, M., Aronovich, A., Farre, M., Feilding, A., Obiols, J. E., & Bouso, J. C. (2021). The Shipibo ceremonial use of ayahuasca to promote well-being: An observational study. Frontiers in Pharmacology, 12(1059), 1-12. https://doi.org/https://doi.org/10.3389/fphar.2021.623923
- Google. (2021). Google Forms. Retrieved from https://www.google.com/forms/about/
- Grob, C. S., McKenna, D. J., Callaway, J. C., Brito, G. S., Neves, E. S., Oberlaender, G., Saide, O. L., Labigalini, E., Tacla, C., Miranda, C. T., Strassman, R. J., & Boone, K. B. (1996). Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. The Journal of Nervous and Mental Disease, 184(2), 86–94. https://doi.org/https://doi.org/10.1097/00005053-199602000-00004
- Halpern, J. H. (1996). The use of hallucinogens in the treatment of addiction. Addiction Research, 4(2), 177–189. https://doi.org/https://doi.org/10.3109/16066359609010756
- Halpern, J., Sherwood, A., Passie, T., Blackwell, K., & Ruttenber, A. (2008). Evidence of health and safety in american members of a religion who use a hallucinogenic sacrament. Medical Science Monitor, 14, SR15–22.
- Hamill, J., Hallak, J., Dursun, S. M., & Baker, G. (2019). Ayahuasca: Psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 17(2), 108–128. https://doi.org/https://doi.org/10.2174/1570159X16666180125095902
- IMB Corp. (2016). IBM SPSS Statistics for windows, version 24.0. IBM Corp.
- Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983–992. https://doi.org/https://doi.org/10.1177/0269881114548296
- Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017). Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse, 43(1), 55–60. https://doi.org/https://doi.org/10.3109/00952990.2016.1170135
- Kavenská, V., & Simonová, H. (2015). Ayahuasca tourism: Participants in shamanic rituals and their personality styles, motivation, benefits and risks. Journal of Psychoactive Drugs, 47(5), 351–359. https://doi.org/https://doi.org/10.1080/02791072.2015.1094590
- Krebs, T. S., & Johansen, P. (2012). Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 26(7), 994–1002. https://doi.org/https://doi.org/10.1177/0269881112439253
- Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. (2016). Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology, 233(18), 3395–3403. https://doi.org/https://doi.org/10.1007/s00213-016-4377-8
- Labate, B. C., & Cavnar, C. (2014). Ayahuasca shamanism in the Amazon and beyond. Oxford: University Press.
- Lawn, W., Hallak, J. E., Crippa, J. A., Dos Santos, R., Porffy, L., Barratt, M. J., Ferris, J. A., Winstock, A. R., & Morgan, C. J. A. (2017). Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: A large, international, self-selecting online survey. Scientific Reports, 7(1), 15201. https://doi.org/https://doi.org/10.1038/s41598-017-14700-6
- Loizaga-Velder, A., & Verres, R. (2014). Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence - qualitative results. Journal of Psychoactive Drugs, 46(1), 63–72. https://doi.org/https://doi.org/10.1080/02791072.2013.873157
- Luna, L. E. (2011). Indigenous and mestizo use of ayahuasca: An overview. In R. dos Santos (Ed.), The ethnopharmacology of ayahuasca (pp. 1–21). Transworld Research Network.
- MacRae, E. (1992). Guided by the moon – Shamanism and the ritual use of ayahuasca in the Santo Daime religion in Brazil. Retrieved from http://www.neip.info/downloads/edward/contents.htms
- Maia, L. O., Daldegan-Bueno, D., & Tófoli, L. F. (2021). The ritual use of ayahuasca during treatment of severe physical illnesses: A qualitative study. Journal of Psychoactive Drugs, 53(3), 272–211. https://doi.org/https://doi.org/10.1080/02791072.2020.1854399
- Majić, T., Schmidt, T. T., & Gallinat, J. (2015). Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Journal of Psychopharmacology, 29(3), 241–253. https://doi.org/https://doi.org/10.1177/0269881114568040
- McKenna, D. J., Towers, G. H., & Abbott, F. (1984). Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and beta-carboline constituents of ayahuasca. Journal of Ethnopharmacology, 10(2), 195–223. https://doi.org/https://doi.org/10.1016/0378-8741(84)90003-5
- Ministério da Saúde. (2012). Resolução n° 466, de 12 de dezembro de 2012. Retrieved from https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html
- Moreira-Almeida, A., Lotufo Neto, F., & Koenig, H. G. (2006). Religiousness and mental health: A review. Revista Brasileira de Psiquiatria, 28(3), 242–250. https://doi.org/https://doi.org/10.1590/S1516-44462006005000006
- Murphy-Beiner, A., & Soar, K. (2020). Ayahuasca’s ‘afterglow’: Improved mindfulness and cognitive flexibility in ayahuasca drinkers. Psychopharmacology, 237(4), 1161–1169. https://doi.org/https://doi.org/10.1007/s00213-019-05445-3
- Muttoni, S., Ardissino, M., & John, C. (2019). Classical psychedelics for the treatment of depression and anxiety: A systematic review. Journal of Affective Disorders, 258, 11–24. https://doi.org/https://doi.org/10.1016/j.jad.2019.07.076
- Oliveira-Lima, A. J., Santos, R., Hollais, A. W., Gerardi-Junior, C. A., Baldaia, M. A., Wuo-Silva, R., Yokoyama, T. S., Costa, J. L., Malpezzi-Marinho, E. L. A., Ribeiro-Barbosa, P. C., Berro, L. F., Frussa-Filho, R., & Marinho, E. A. V. (2015). Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice. Physiology & Behavior, 142, 28–36. https://doi.org/https://doi.org/10.1016/j.physbeh.2015.01.032
- Osório, F. d L., Sanches, R. F., Macedo, L. R., Santos, R. G. d., Maia-de-Oliveira, J. P., Wichert-Ana, L., Araujo, D. B. d., Riba, J., Crippa, J. A., & Hallak, J. E. (2015). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista Brasileira de Psiquiatria, 37(1), 13–20.https://doi.org/https://doi.org/10.1590/1516-4446-2014-1496
- Otsuka Nunes, L. Y., Campos Lopes Lemos, D., de Castro Ribas Júnior, R., Brandão Behar, C., & Pires dos Santos, P. P. (2019). Análise psicométrica da PANAS no Brasil. Ciencias Psicológicas, 13, 45–55. https://doi.org/http://dx.doi.org/10.22235/cp.v13i1.1808
- Ott, J. (1999). Pharmahuasca: Human pharmacology of oral DMT plus harmine. Journal of Psychoactive Drugs, 31(2), 171–177. https://doi.org/https://doi.org/10.1080/02791072.1999.10471741
- Pahnke, M. W. (1969). The psychedelic mystical experience in the human encounter with death. Harvard Theological Review, 62(1), 1–21. https://doi.org/https://doi.org/10.1017/S0017816000027577
- Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., Dos Santos, R. G., Tófoli, L. F., de Oliveira Silveira, G., Yonamine, M., Riba, J., Santos, F. R., Silva-Junior, A. A., Alchieri, J. C., Galvão-Coelho, N. L., Lobão-Soares, B., … Araújo, D. B. (2019). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine, 49(4), 655–663. https://doi.org/https://doi.org/10.1017/S0033291718001356
- Perkins, D., Opaleye, E. S., Simonova, H., Bouso, J. C., Tófoli, L. F., GalvÃo-Coelho, N. L., Schubert, V., & Sarris, J. (2022). Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey. Drug and Alcohol Review, 41(1), 265–274. https://doi.org/https://doi.org/10.1111/dar.13348
- Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001). Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology, 154(1), 85–95. https://doi.org/https://doi.org/10.1007/s002130000606
- Rodrigues, L. S., Rossi, G. N., Rocha, J. M., L Osório, F., Bouso, J. C., Hallak, J. E. C., & dos Santos, R. G. (2021). Effects of ayahuasca and its alkaloids on substance use disorders: An updated (2016–2020) systematic review of preclinical and human studies. European Archives of Psychiatry and Clinical Neuroscience. Advance online publication. https://doi.org/https://doi.org/10.1007/s00406-021-01267-7
- Sampedro, F., de la Fuente Revenga, M., Valle, M., Roberto, N., Domínguez-Clavé, E., Elices, M., Luna, L. E., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., Friedlander, P., Barker, S. A., Álvarez, E., Soler, J., Pascual, J. C., Feilding, A., & Riba, J. (2017). Assessing the psychedelic "after-glow" in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. The International Journal of Neuropsychopharmacology, 20(9), 698–711. https://doi.org/https://doi.org/10.1093/ijnp/pyx036
- Santos, R. G. D., Sanches, R. F., Osório, F. d L., & Hallak, J. E. C. (2018). Long-term effects of ayahuasca in patients with recurrent depression: A 5-year qualitative follow-up. Archives of Clinical Psychiatry, 45(1), 22–24.https://doi.org/https://doi.org/10.1590/0101-60830000000149
- Schultes, R. E., & Hofmann, A. (1979). Plants of the gods: Origins of hallucinogenic use. McGraw-Hill.
- Sessa, B., & Johnson, M. W. (2015). Can psychedelic compounds play a part in drug dependence therapy? British Journal of Psychiatry, 206(1), 1–3. https://doi.org/https://doi.org/10.1192/bjp.bp.114.148031
- Soler, J., Elices, M., Dominguez-Clavé, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., García-Campayo, J., & Riba, J. (2018). Four weekly ayahuasca sessions lead to increases in “Acceptance” capacities: A comparison study with a standard 8-week mindfulness training program. Frontiers in Pharmacology, 9(224), 224. https://doi.org/https://doi.org/10.3389/fphar.2018.00224
- Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016). Exploring the therapeutic potential of Ayahuasca: Acute intake increases mindfulness-related capacities. Psychopharmacology, 233(5), 823–829. https://doi.org/https://doi.org/10.1007/s00213-015-4162-0
- Taunay, T. C., Cristino, E. D., Machado, M. O., Rola, F. H., Lima, J. W., Macêdo, D. S., Gondim, F. d A. A., Moreira-Almeida, A., & Carvalho, A. F. (2012). Development and validation of the Intrinsic Religiousness Inventory (IRI). Revista Brasileira de Psiquiatria, 34(1), 76–81.https://doi.org/https://doi.org/10.1590/S1516-44462012000100014
- Thomas, G., Lucas, P., Capler, N. R., Tupper, K. W., & Martin, G. (2013). Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews, 6(1), 30–42. https://doi.org/https://doi.org/10.2174/15733998113099990003
- Udenfriend, S., Witkop, B., Redfield, B. G., & Weissbach, H. (1958). Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compounds. Biochemical Pharmacology, 1(2), 160–165. doi: https://doi.org/https://doi.org/10.1016/0006-2952(58)90025-X
- Uthaug, M. V., van Oorsouw, K., Kuypers, K. P. C., van Boxtel, M., Broers, N. J., Mason, N. L., Toennes, S. W., Riba, J., & Ramaekers, J. G. (2018). Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology, 235(10), 2979–2989. https://doi.org/https://doi.org/10.1007/s00213-018-4988-3
- Vilaró, M. T., Cortés, R., Mengod, G., & Hoyer, D. (2020). Chapter 6 – Distribution of 5-HT receptors in the central nervous system: An update. In C. P. Müller & K. A. Cunningham (Eds.), Handbook of behavioral neuroscience (Vol. 31, pp. 121–146). Elsevier.
- Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Copyright © 1988 by the American Psychological Association. Reproduced with permission. Journal of Personality and Social Psychology, 54(6), 1063–1070. https://doi.org/https://doi.org/10.1037//0022-3514.54.6.1063
- WHOQOL. (1996). WHOQOL-BREF: Introduction, administration, scoring and generic version of the assessment - field trial version, December 1996. World Health Organization.
- WHOQOL. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28(3), 551–558. https://doi.org/https://doi.org/10.1017/s0033291798006667
- Winkelman, M. (2005). Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia. Journal of Psychoactive Drugs, 37(2), 209–218. https://doi.org/https://doi.org/10.1080/02791072.2005.10399803
- Zanon, C., Bardagi, M. P., Layous, K., & Hutz, C. S. (2014). Validation of the Satisfaction with Life Scale to Brazilians: Evidences of measurement noninvariance across Brazil and US. Social Indicators Research, 119(1), 443–453. https://doi.org/https://doi.org/10.1007/s11205-013-0478-5
- Zeifman, R. J., Singhal, N., Dos Santos, R. G., Sanches, R. F., de Lima Osório, F., Hallak, J. E. C., & Weissman, C. R. (2021). Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: Results from an open-label trial. Psychopharmacology, 238(2), 453–459. https://doi.org/https://doi.org/10.1007/s00213-020-05692-9
- Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. https://doi.org/https://doi.org/10.1111/j.1600-0447.1983.tb09716.x